DDR2 and breast neoplasm: In breast tumor cells, Li et al. demonstrated that DDR2 promotes tumor cell quiescence by inducing cell cycle arrest via the STAT1/p27 pathway, whereas intβ1/β3 enhances stem-like traits and tumorigenic potential receptors under low ECM stiffness [93].